hVIVO plc (LON:HVO – Get Free Report) dropped 6.8% during mid-day trading on Thursday . The stock traded as low as GBX 19 ($0.24) and last traded at GBX 19.10 ($0.24). Approximately 2,518,262 shares were traded during mid-day trading, a decline of 26% from the average daily volume of 3,389,765 shares. The stock had previously closed at GBX 20.50 ($0.26).
hVIVO Price Performance
The stock has a 50 day moving average of GBX 23.58 and a 200-day moving average of GBX 26.77. The company has a debt-to-equity ratio of 33.86, a quick ratio of 1.16 and a current ratio of 1.61. The company has a market cap of £129.95 million, a PE ratio of 636.67 and a beta of 0.97.
hVIVO Company Profile
hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
Featured Stories
- Five stocks we like better than hVIVO
- How to trade using analyst ratings
- 3 Legacy Tech Companies Reemerging as AI Leaders
- 5 discounted opportunities for dividend growth investors
- Analysts’ Favorite Cybersecurity Stocks: 3 Top Picks
- Market Cap Calculator: How to Calculate Market Cap
- Analysts Are Bullish: 3 Tech Giants With Upgraded Price Targets
Receive News & Ratings for hVIVO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for hVIVO and related companies with MarketBeat.com's FREE daily email newsletter.
